Skip to main content
. 2019 Dec 3;12:301–308. doi: 10.2147/JIR.S220960

Table 1.

Demographic, Clinical and Laboratory Features of RA Subjects and HCs

RA n=84 HCs n=79
Age, years 59.0 ± 9.9 46.7 ± 11.6
Female sex, n (%) 65 (77.38) 54 (68.35)
Disease duration, months 145 ± 134
ACPA positivity, n (%) 68.6
RF positivity, n (%) 74.5
HAQ (0–3) 0.92 ± 0.73
DAS-28 3.72 ± 1.38
CRP, mg/dL 0.88 ± 0.96
ESR, mm/h 30.7 ± 25.8
Steroids use, n (%) 43.4
DMARDs use, n (%) 66.3
Anti-TNF use, n (%) 24.1
Tocilizumab use, n (%) 12
Abatacept use, n (%) 4.9